Catalyst Pharmaceuticals Inc — Balance Sheet (NASDAQ:CPRX) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Total assets 192.35 M237.79 M375.63 M470.11 M851.41 M1.1 B Total liabilities 22.76 M30.96 M75.21 M82.23 M123.78 M149.71 M Total equity 169.6 M206.83 M300.42 M387.88 M727.63 M954.27 M Total liabilities & shareholders' equities 192.35 M237.79 M375.63 M470.11 M851.41 M1.1 B Total debt —————— Net debt ——————

Nachrichten

Oppenheimer bestätigt Catalyst-Rating nach Umsatzüberraschung

Oppenheimer reiterates Catalyst Pharmaceutical stock rating on revenue beat

Catalyst Pharmaceuticals Q4 Earnings Beat, Firdapse Revenues Rise Y/Y

Catalyst Pharmaceuticals: EPS übertrifft Schätzungen um 0,37 $ - Umsatz besser als erwartet

Catalyst Pharmaceuticals vor Quartalszahlen: Wachstumsfragen im Fokus

BioCryst Pharmaceuticals (BCRX) Earnings Expected to Grow: Should You Buy?

Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Tops Revenue Estimates

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term

Stock Market Today: Dow Gains As Disney Dives, Pharma Play Eyes Entry, Oracle Pops On This (Live Coverage)

Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock

Jim Cramer: Crane Is A 'Good' Company, Recommends Holding This Tech Stock - Baker Hughes (NASDAQ:BKR), Catalyst Pharmaceuticals (NASDAQ:CPRX)